IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Xilio Therapeutics Inc (XLO)

CUSIP: 98422T100 | NYSE | Healthcare · Biotechnology | Small Cap | 105 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Gilead Sciences, Inc.650,389
0.4% of portfolio›$6.2M
StyleTurnoverLocationFiled
Gilead Sciences, Inc.
650,389$6.2M0.4%Deep ValueVery LowFoster City, CA2026-08-03